Novo Nordisk A/S ADR buy StockNews.com
Start price
14.12.24
/
50%
€102.50
Target price
14.12.25
-
Performance (%)
-58.15%
End price
15.12.25
€42.90
Summary
This prediction ended on 15.12.25 with a price of €42.90. Massive losses of -58.15% were the result for the BUY prediction by StockNews_com. Dividends of €1.10 are taken into consideration when calculating the performance. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Novo Nordisk A/S ADR | 7.563% | 7.563% | -32.510% |
| iShares Core DAX® | 3,59 % | 3,93 % | 15,38 % |
| iShares Nasdaq 100 | 5,81 % | 5,52 % | 41,46 % |
| iShares Nikkei 225® | 4,08 % | 8,46 % | 48,95 % |
| iShares S&P 500 | 4,14 % | 4,04 % | 31,59 % |
Comments by StockNews_com for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
Novo Nordisk A/S (NYSE: NVO) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Ratings data for NVO provided by MarketBeat
In the thread Trading Novo Nordisk A/S ADR
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten